NO913232L - Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse. - Google Patents

Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.

Info

Publication number
NO913232L
NO913232L NO91913232A NO913232A NO913232L NO 913232 L NO913232 L NO 913232L NO 91913232 A NO91913232 A NO 91913232A NO 913232 A NO913232 A NO 913232A NO 913232 L NO913232 L NO 913232L
Authority
NO
Norway
Prior art keywords
analogs
production
pdgf
present
growth factor
Prior art date
Application number
NO91913232A
Other languages
English (en)
Norwegian (no)
Other versions
NO913232D0 (no
Inventor
Arlen Read Thomason
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/454,794 external-priority patent/US5149792A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO913232L publication Critical patent/NO913232L/no
Publication of NO913232D0 publication Critical patent/NO913232D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/49Platelet-derived growth factor [PDGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO913232A 1989-12-19 1991-08-19 Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse. NO913232D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/454,794 US5149792A (en) 1989-12-19 1989-12-19 Platelet-derived growth factor B chain analogs
US07/624,451 US5272064A (en) 1989-12-19 1990-12-13 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
PCT/US1990/007451 WO1991008761A1 (en) 1989-12-19 1990-12-17 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof

Publications (2)

Publication Number Publication Date
NO913232L true NO913232L (no) 1991-08-19
NO913232D0 NO913232D0 (no) 1991-08-19

Family

ID=27037609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913232A NO913232D0 (no) 1989-12-19 1991-08-19 Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.

Country Status (17)

Country Link
US (1) US5272064A (xx)
EP (1) EP0458959B1 (xx)
JP (1) JPH04504064A (xx)
AT (1) ATE123949T1 (xx)
AU (1) AU646014B2 (xx)
CA (1) CA2032675A1 (xx)
DE (1) DE69020335T2 (xx)
DK (1) DK0458959T3 (xx)
ES (1) ES2073735T3 (xx)
FI (1) FI913892A0 (xx)
GR (1) GR3017317T3 (xx)
IE (1) IE904608A1 (xx)
IL (1) IL96723A0 (xx)
NO (1) NO913232D0 (xx)
NZ (1) NZ236549A (xx)
PT (1) PT96272A (xx)
WO (1) WO1991008761A1 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07507055A (ja) * 1992-02-26 1995-08-03 アラーガン、インコーポレイテッド 眼の創傷の治癒における血小板誘導化成長因子の使用
WO1993020204A1 (en) * 1992-03-30 1993-10-14 Schering Corporation Monomeric platelet-derived growth factor and prevention of stenosis or restenosis
AU2003220529B2 (en) 2002-03-27 2006-09-07 Immunex Corporation Methods for increasing polypeptide production
US20040248796A1 (en) * 2003-02-04 2004-12-09 Kari Alitalo VEGF-B and PDGF modulation of stem cells
CN102471769A (zh) 2009-07-17 2012-05-23 亚伦·T.·塔波尔 用于具有美容功能的细胞的遗传修饰以提高美容外观的方法和组合物
WO2012019160A1 (en) 2010-08-05 2012-02-09 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures
PL2699293T3 (pl) 2011-04-20 2019-08-30 Amgen Inc. Urządzenie do wstrzykiwania automatycznego
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
CN103827292B (zh) 2011-07-01 2018-01-26 安姆根有限公司 哺乳动物细胞培养
CA2840637A1 (en) 2011-09-02 2013-03-07 Amgen Inc. Pharmaceutical product and method of analysing light exposure of a pharmaceutical product
AR089231A1 (es) 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
WO2014109858A1 (en) 2013-01-14 2014-07-17 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
TWI832345B (zh) 2013-03-14 2024-02-11 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
SI2969099T2 (sl) 2013-03-14 2022-04-29 Amgen Inc. Odstranjevanje izluženega afinitetnega purifikacijskega liganda
US10092703B2 (en) 2013-03-15 2018-10-09 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
EP2968736A4 (en) 2013-03-15 2016-11-09 Amgen Inc ADJUSTABLE TO A BODY SHAPE AUTO INJECTOR DEVICE
EP3593839A1 (en) 2013-03-15 2020-01-15 Amgen Inc. Drug cassette
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
EP3063287A1 (en) 2013-10-31 2016-09-07 Amgen Inc. Use of monensin to regulate glycosylation of recombinant proteins
EP3094735A1 (en) 2014-01-13 2016-11-23 Amgen Inc. Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins
US10106829B2 (en) 2014-01-29 2018-10-23 Amgen Inc. Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
KR102519540B1 (ko) 2014-01-29 2023-04-10 암젠 인크 재조합 단백질의 글리코실화를 조절하기 위한 n-글리코실화 경로 조절자의 과발현
PL3152317T3 (pl) 2014-06-04 2019-08-30 Amgen Inc. Sposoby zbierania hodowli ssaczych komórek
US11275090B2 (en) 2014-11-19 2022-03-15 Amgen Inc. Quantitation of glycan moiety in recombinant glycoproteins
CA2969225C (en) 2014-12-01 2023-08-22 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
AU2018368338B2 (en) 2017-11-16 2024-07-25 Amgen Inc. Autoinjector with stall and end point detection
CA3099163A1 (en) 2018-05-01 2019-11-07 Amgen Inc. Antibodies with modulated glycan profiles
WO2023079058A1 (en) 2021-11-05 2023-05-11 Yokogawa Insilico Biotechnology Gmbh Cell culture with reduced production of lactate
KR20240128067A (ko) 2021-12-29 2024-08-23 브리스톨-마이어스 스큅 컴퍼니 랜딩 패드 세포주의 생성

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4769328A (en) * 1984-10-12 1988-09-06 Zymogenetics Inc. Expression of biologically active PDGF analogs in yeast
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0487116B1 (en) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Biologically active PDGF analogs in eucaryotic cells
DE3751632T2 (de) * 1986-08-13 1996-06-13 Zymogenetics Inc Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen
DE3834079A1 (de) * 1988-10-06 1990-04-12 Biotechnolog Forschung Gmbh Wachstumstimulierendes pdgf-bb und dessen verwendung sowie ein verfahren zu seiner herstellung und der des monomeren
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems

Also Published As

Publication number Publication date
AU646014B2 (en) 1994-02-03
CA2032675A1 (en) 1991-06-20
DE69020335T2 (de) 1995-11-02
NO913232D0 (no) 1991-08-19
DE69020335D1 (de) 1995-07-27
ES2073735T3 (es) 1995-08-16
ATE123949T1 (de) 1995-07-15
EP0458959A1 (en) 1991-12-04
AU7153491A (en) 1991-07-18
WO1991008761A1 (en) 1991-06-27
EP0458959A4 (en) 1993-06-16
US5272064A (en) 1993-12-21
IL96723A0 (en) 1991-09-16
FI913892A0 (fi) 1991-08-16
IE904608A1 (en) 1991-06-19
GR3017317T3 (en) 1995-12-31
DK0458959T3 (da) 1995-08-14
NZ236549A (en) 1993-03-26
EP0458959B1 (en) 1995-06-21
JPH04504064A (ja) 1992-07-23
PT96272A (pt) 1991-09-30

Similar Documents

Publication Publication Date Title
NO913232L (no) Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.
Heldin et al. Chemical and biological properties of a growth factor from human‐cultured osteosarcoma cells: Resemblance with platelet‐derived growth factor
Waterfield et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus
KR880007734A (ko) 폴리펩타이드 유도체
Burgess et al. Two forms of murine epidermal growth factor: rapid separation by using reverse-phase HPLC.
KR880701105A (ko) 신규 응혈촉진 단백질
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
LU90408I2 (fr) Regranex-becaplermin
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
DE3650540D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
ATE91722T1 (de) Pferde-gamma-interferon.
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
DE3852706D1 (de) Verfahren zur Herstellung eines physiologisch aktiven Peptids mit einem Cysteinrest.
AU7681687A (en) Expression of platelet-derived growth factor and analogues
ATE103931T1 (de) Polypeptide aus vipergift und deren genexpression.
PT100651A (pt) Muteinas da interleucina 6 (il-6) isentas de cisteina
Proost et al. Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines
KR880701073A (ko) 제조합 dna 기법에 의해 생성된 민악티빈
ATE141645T1 (de) In vitro-behandlung von fusionsproteinen
SE8502430D0 (sv) A cdna molecule coding for the expression of an interferon alfa type polypeptide, a bacterial or cellular host transformed with such molecule and a polypeptide showing interferon activity prepared by such host
JPS6437291A (en) Human cytochrome c gene and use thereof
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
JPS642583A (en) Recombinant dna and production of polypeptide using said dna
EP1679372A4 (en) NEW PLEXIN POLYPEPTIDE, THIS CODING DNA AND USE THEREOF